CNB Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11
Closed -$3.86K 526
2025
Q4
$3.86K Hold
11
﹤0.01% 453
2025
Q3
$3.55K Sell
11
-11
-50% -$3.42K ﹤0.01% 453
2025
Q2
$8.56K Hold
22
﹤0.01% 396
2025
Q1
$9.57K Sell
22
-2
-8% -$803 ﹤0.01% 365
2024
Q4
$8.85K Hold
24
﹤0.01% 391
2024
Q3
$12.5K Hold
24
0.01% 387
2024
Q2
$13K Hold
24
0.01% 371
2024
Q1
$12.4K Buy
24
+2
+9% +$995 0.01% 364
2023
Q4
$10.4K Hold
22
0.01% 360
2023
Q3
$9.58K Buy
22
+11
+100% +$4.99K 0.01% 364
2023
Q2
$4.89K Hold
11
﹤0.01% 372
2023
Q1
$5.06K Hold
11
﹤0.01% 393
2022
Q4
$5.64K Hold
11
﹤0.01% 359
2022
Q3
$5K Hold
11
﹤0.01% 368
2022
Q2
$5K Hold
11
﹤0.01% 354
2022
Q1
$5K Hold
11
﹤0.01% 362
2021
Q4
$5K Buy
+11
New +$4.63K ﹤0.01% 359

Other funds holding ELV

CNB Bank's ELV Position: Q1 2026 in Review

CNB Bank sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 11 shares — an estimated $3.86K sold.

CNB Bank first reported a position in ELV in Q4 2021 and held it in 17 quarters. The position peaked at $13K in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • CNB Bank reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • CNB Bank sold 11 Elevance Health shares in Q1 2026, an estimated $3.86K.
  • CNB Bank first reported a position in Elevance Health in Q4 2021 and held it in 17 quarters.
  • CNB Bank's Elevance Health position peaked at $13K in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.